OTC: JWCTF - JW (Cayman) Therapeutics Co. Ltd

Altı ay boyunca karlılık: -43.16%
Sektör: Healthcare

Promosyon programı JW (Cayman) Therapeutics Co. Ltd

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People's Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers.

daha fazla ayrıntı
The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

EBITDA -0.3143
EV/EBITDA 0.5634
Industry Biotechnology
P/BV 1.82
P/S 164.53
Sector Health Care
Валюта usd
Валюта отчета cny
Выручка 0.0055
Сайт https://www.jwtherapeutics.com
Цена ао 0.255
Число акций ао 0.41153 млрд
Günlük fiyat değişimi: +0.3717% (0.1614)
Haftalık fiyat değişimi: -4.59% (0.1698)
Aylık fiyat değişimi: -36.47% (0.255)
3 ayda fiyat değişimi: -20.59% (0.204)
Altı ayda fiyat değişimi: -43.16% (0.285)
Yıllık fiyat değişimi: -39.37% (0.2672)
3 yılda fiyat değişimi: -88.98% (1.47)
5 yılda fiyat değişimi: -0% (0.162)
10 yılda fiyat değişimi: -0% (0.162)
Yılbaşından bu yana fiyat değişimi: -4.59% (0.1698)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 4.52 3
P/BV 0.4665 10
P/E 0 0
EV/EBITDA -0.2077 0
Toplam: 5.38

Yeterlik

İsim Anlam Seviye
ROA, % -35.79 0
ROE, % -45.61 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.588 10
Toplam: 9.6

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 3070.82 10
karlılık Ebitda, % 108.61 10
karlılık EPS, % 9.47 2
Toplam: 6.2
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
DFA Emerging Markets Small Cap Series 467500 0.11
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 336309 0.08
DFA Emerging Markets Core Equity Portfolio 98500 0.02
Dimensional ETF Tr-Dimensional Emerging Markets Core Equity 2 ETF 95500 0.02
SPDR (R) Idx Shares-SPDR (R) S&P (R) China ETF 76500 0.02
Dimensional ETF Tr-Dimensional World ex U.S. Core Equity 2 ETF 69500 0.02
DFA Investment Dimensions-World Ex U.S. Core Equity Port 55500 0.01
SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF 42350 0.01
DFA Investment Dimensions-DFA Emerging Markets Targeted Value Port 38000 0.01
Avantis Emerging Markets Equity ETF 36000 0.01



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Yiping Li M.D. Co-Founder & Interim Chairman 836.74k 1964 (61 yıl)
Cao Xiaoping Ph.D. Senior Vice President of Tech Operations N/A
Dr. Shaun Paul Cordoba Ph.D. Senior VP & Chief Scientific Officer N/A 1980 (45 yıllar)
Mr. Raymond J. Hage Jr. Senior Vice President of Corporate Development N/A 1968 (57 yıllar)
Mr. Mark J. Gilbert M.D. Senior Advisor & Acting Chief Medical Officer N/A
Ms. Ka Man Ng A.C.I.S., A.C.S. Company Secretary N/A 1978 (47 yıllar)
Mr. Qiang Ma Senior VP & Chief Commercial Officer N/A 1978 (47 yıllar)
Ms. Yun Qin Senior Vice President of Clinical Sciences & Medical Services N/A 1982 (43 yıl)
Dr. Su Yang Senior Vice President Of Clinical Research & PMO N/A 1979 (46 yıllar)
Mr. Min Liu CEO & Executive Director 1973 (52 yıl)

Adres: China, Shanghai, Building B - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.jwtherapeutics.com